王林医生简介

王林，1983年出生；主任医师、副教授

北京大学肿瘤医院 知名专家

专业特长：
直肠癌、结肠癌的外科治疗
直肠癌综合治疗，低位保肛和综合治疗
恶性肠梗阻、腹腔转移癌的减瘤手术
手术例数：300台/年

专业履历：
17岁，北京大学医学部长学制；
27岁，北京大学外科学博士、主治医师；
32岁，副主任医师；
34岁，副教授；
38岁，主任医师；
42岁，知名专家；

医学世家：
北大肿瘤第三代医生：
祖父王余泰教授，北大肿瘤首任肿瘤内科主任；
祖母张慧生教授，北京大学第一医院普外科及门急诊护士长、澳门镜湖医院护理部主任；

留学经历：
斯隆凯特琳癌症中心（MSKCC）结直肠外科临床研究员 (2013~2014)，进行了直肠癌等待观察疗法和直肠间质瘤的相关研究；

中华胃肠外科杂志，编委

2018年CSCO "35 under 35" 奖：35岁以下35名优秀肿瘤学医生，及当年最佳科研奖；

代表论著：【1-30】
1. Wang L, et al. Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. World journal of surgery. 2010;34(5):1080-5. 10.1007/s00268-010-0449-9.
2. Yao YF, Wang L, ,et al. Lymph node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. Journal of clinical pathology. 2011;64(12):1073-7. 10.1136/jclinpath-2011-200190.
3. 王林，等. 新辅助放化疗对直肠癌降期的影响. 中国普外基础与临床杂志. 2011;18(11):1147-50.
4. 王林，等. 结直肠癌的规范化病理诊断要点. 中华胃肠外科杂志. 2012;15(10):1088-91.
5. 王林，等. IIa期结肠癌的预后因素. 世界华人消化杂志. 2012;20(36):3816-21.
6. Wang L, et al. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: Unfavorable prognosis even with negative circumferential resection margin. World journal of gastroenterology : WJG. 2014;20(27):9138-45. 10.3748/wjg.v20.i27.9138.
7. Wang L, et al. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014;16(1):33-9. 10.1111/codi.12354.
8. 王林, 等. 直肠恶性肿瘤的新辅助治疗：研究现状与外科决策. 中华普通外科学文献（电子版）. 2014(3):176-80. 10.3877/cma.j.issn.1674-0793.2014.03.001.
9. 王林, 等. 腹会阴联合切除术历史回顾及现状. 中国实用外科杂志. 2014;34(9):812-6.
10. 王林, 等. 淋巴结比率对术前30 Gy／10次分割放疗后Ⅲ期直肠癌患者预后的判断价值. 中华胃肠外科杂志. 2014(10):990-6. 10.3760/cma.j.issn.1671-0274.2014.10.010.
11. Wang L, Paty P. Open Abdominoperineal Resection. In: Kim J, Garcia-Aguilar J, editors. Surgery for Cancers of the Gastrointestinal Tract: A Step-by-Step Approach. New York, NY: Springer New York; 2015. p. 263-74.
12. Wang L, et al. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Diseases of the colon and rectum. 2015;58(2):186-92. 10.1097/DCR.0000000000000294.
13. Wang L, et al. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy. International journal of colorectal disease. 2015;30(6):753-60. 10.1007/s00384-015-2226-6.
14. Wang L, et al. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years. Clinical colorectal cancer. 2016;15(2):152-7. 10.1016/j.clcc.2015.10.001.
15. Cavnar MJ, Wang L, et al. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome. Annals of surgical oncology. 2017;24(13):3972-80. 10.1245/s10434-017-6087-9.
16. 武爱文, 王林, 等. 中低位直肠癌新辅助治疗后等待观察或器官保留手术的单中心35例报告. 中华胃肠外科杂志. 2017;20(4):417-24.
17. Wu AW, Cai Y, Li YH, Wang L, et al. Pattern and Management of Recurrence of Mid-Low Rectal Cancer After Neoadjuvant Intensity-Modulated Radiotherapy: Single-Center Results of 687 Cases. Clinical colorectal cancer. 2018;17(2):e307-e13. 10.1016/j.clcc.2018.01.006.
18. 王林,武爱文, 等. 中低位直肠癌新辅助治疗后临床完全缓解或近临床完全缓解的长期预后分析. 中华胃肠外科杂志. 2018;21(11):1240-8.
19. Chen N, Wang L, Wu AW, et al. Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes. World J Gastrointest Oncol. 2019;11(10):877-86. 10.4251/wjgo.v11.i10.877.
20. Song M, Geng J, Wang L, et al. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer. Radiat Oncol. 2019;14(1):138. 10.1186/s13014-019-1338-5.
21. 孙婷婷, 王林,武爱文, 等. 直肠癌新辅助治疗后"等待观察"疗法:中国外科医生的认知和态度及治疗选择现况调查. 中华胃肠外科杂志. 2019;22(6).
22. Chen PJ, Wang L, Wu AW, et al. Surgical intervention for malignant bowel obstruction caused by gastrointestinal malignancies. World J Gastrointest Oncol. 2020;12(3):323-31. 10.4251/wjgo.v12.i3.323.
23. Sun RJ, Wang L, et al. Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer. Journal of cancer research and clinical oncology. 2020;146(3):739-48. 10.1007/s00432-019-03100-0.
24. Zhang XY, Wang L, et al. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI. Radiology. 2020:190936. 10.1148/radiol.2020190936.
25. 王林,武爱文, 等. 低风险直肠癌患者全程新辅助治疗后主动性 等待观察及器官保留策略：一项前瞻性、 单中心、单臂研究（PKUCH⁃R01）的初步报告. 中华胃肠外科杂志. 2020;23(3):258-65.
26. 中国直肠癌新辅助治疗后等待观察数据库研究协作组, 中国医师协会外科医师分会中国医师协会肛肠医师分会, 中华医学会外科学分会结直肠外科学组, 中国医师协会结直肠肿瘤医师专业委员会, 中国抗癌协会放射治疗专业委员会. 直肠癌新辅助治疗后等待观察策略专家共识（2020版）. 中华胃肠外科杂志. 2020;23(01):1-9.
27. 中国直肠癌新辅助治疗后等待观察数据库研究协作组（CWWD）, 中国医师协会外科医师分会, 中国卫生法学会, 中国医师协会肛肠医师分会, 中国医师协会放射肿瘤治疗医师分会, 北京卫生法学会医事法律专业委员会, 北京卫生法学会患者安全专业委员会. 直肠癌新辅助治疗后等待观察策略患者权益保护专家共识. 中华胃肠外科杂志. 2020;23(03):220-4.
28. Li S, Geng J, Wang L, Teng H, Wang Z, Zhu X, Zhang Y, Wang H, Li Y, Cai Y, Wu A, Wang W. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node. Cancer Manag Res. 2021;13:537-46. 10.2147/CMAR.S286796. PMC7837555.
29. Zhang XY, Li XT, Shi YJ, Lu QY, Cao W, Zhang HM, Wang L, Zhu HT, Yu T, Guan Z, Sun RJ, Zhu HB, Wu AW, Sun YS. Correlation Between the Distance to Mesorectal Fascia and Prognosis of Ct3 Rectal Cancer: A Multicenter Study Results of China. Diseases of the colon and rectum. 2021. 10.1097/DCR.0000000000002167.
30. Li YJ, Wang L, Sun TT, Wu AW. Laparoscopy-assisted transanal total mesorectal excision for lower rectal cancer: A feasible and innovative technique. World J Gastrointest Oncol. 2021;13(1):12-23. 10.4251/wjgo.v13.i1.12. PMC7805274.